Trial Profile
Practical Focus at ADA/EASD Consensus algorithm in type2 Diabetics: Timely Glargine insulin initiation and titration (Morning/Evening) and the evaluation of HbA1C -
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 08 Oct 2012 New trial record
- 27 Jul 2012 Recruitment complete.